Metagenomi Therapeutics, Inc. (MGX)
1.47
-0.05
(-3.29%)
USD |
NASDAQ |
Feb 20, 16:00
1.47
0.00 (0.00%)
After-Hours: 18:14
Metagenomi Therapeutics EPS Diluted (Quarterly) : -0.546 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.39M |
| Revenue (Quarterly) | 8.659M |
| Total Expenses (Quarterly) | 29.05M |
| Enterprise Value | -85.38M |
| Gross Profit Margin (Quarterly) | 84.71% |
| Profit Margin (Quarterly) | -235.5% |
| Earnings Yield | -162.1% |
| Normalized Earnings Yield | -151.41 |